France
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 121.27 B |
Jan. 14, 2025 | USD 96.09 | -1.23% |
|
France |
|
2 |
USD 360.91 M |
Jan. 14, 2025 | USD 2.16 | -2.19% |
|
France |
|
3 |
USD 152.09 M |
Jan. 14, 2025 | USD 6.91 | 0.46% |
|
France |
|
4 |
USD 95.20 M |
Jan. 14, 2025 | USD 4.64 | -14.23% |
|
France |
|
5 |
USD 95.91 K |
Jan. 14, 2025 | USD 0.96 | -6.39% |
|
France |
The Vaccines company in France with the highest Market Capitalization is Sanofi (Paris Stock Exchange: SAN.PA) at USD 121.27 B.
The Vaccines company in France with the lowest Market Capitalization is Neovacs S.A. (Paris Stock Exchange: ALNEV.PA) at USD 95.91 K.
The top 10 Vaccines companies in France by Market Capitalization are Sanofi, Valneva SE, OSE Immunotherapeutics SA, DBV Technologies S.A. and Neovacs S.A..
The bottom 10 Vaccines companies in France by Market Capitalization are Neovacs S.A., DBV Technologies S.A., OSE Immunotherapeutics SA, Valneva SE and Sanofi.